PL4166137T3 - Środek leczniczy na stłuszczeniową chorobę wątroby - Google Patents

Środek leczniczy na stłuszczeniową chorobę wątroby

Info

Publication number
PL4166137T3
PL4166137T3 PL21858322.7T PL21858322T PL4166137T3 PL 4166137 T3 PL4166137 T3 PL 4166137T3 PL 21858322 T PL21858322 T PL 21858322T PL 4166137 T3 PL4166137 T3 PL 4166137T3
Authority
PL
Poland
Prior art keywords
remedy
liver disease
fatty liver
fatty
disease
Prior art date
Application number
PL21858322.7T
Other languages
English (en)
Inventor
Ayatoshi Ando
Ippei KAWANISHI
Seiji Shiraishi
Harumi Tanaka
Yuki Saitou
Original Assignee
Ea Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ea Pharma Co., Ltd. filed Critical Ea Pharma Co., Ltd.
Publication of PL4166137T3 publication Critical patent/PL4166137T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL21858322.7T 2020-08-19 2021-08-18 Środek leczniczy na stłuszczeniową chorobę wątroby PL4166137T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020138703 2020-08-19
PCT/JP2021/030099 WO2022039178A1 (ja) 2020-08-19 2021-08-18 脂肪性肝疾患の治療薬

Publications (1)

Publication Number Publication Date
PL4166137T3 true PL4166137T3 (pl) 2024-08-12

Family

ID=80350445

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21858322.7T PL4166137T3 (pl) 2020-08-19 2021-08-18 Środek leczniczy na stłuszczeniową chorobę wątroby

Country Status (16)

Country Link
US (1) US12023320B2 (pl)
EP (1) EP4166137B1 (pl)
JP (2) JP7286222B2 (pl)
KR (1) KR20230052845A (pl)
CN (1) CN115605198B (pl)
AU (1) AU2021328824B2 (pl)
BR (1) BR112023002069A2 (pl)
CA (1) CA3183428A1 (pl)
DK (1) DK4166137T3 (pl)
ES (1) ES2982263T3 (pl)
FI (1) FI4166137T3 (pl)
MX (1) MX2023001742A (pl)
PL (1) PL4166137T3 (pl)
PT (1) PT4166137T (pl)
TW (1) TWI906348B (pl)
WO (1) WO2022039178A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026063508A1 (ja) * 2024-09-20 2026-03-26 Eaファーマ株式会社 医薬組成物
EP4732836A1 (en) 2024-10-22 2026-04-29 Consejo Superior De Investigaciones Científicas Ag5 compound for use in the treatment of in fatty liver diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102822154B (zh) 2009-12-07 2016-06-01 味之素株式会社 杂芳基羧酸酯衍生物
WO2012169579A1 (ja) 2011-06-07 2012-12-13 味の素株式会社 ヘテロ環カルボン酸エステル誘導体
US9024044B2 (en) 2012-06-14 2015-05-05 Ajinomoto Co., Inc. Heteroarylcarboxylic acid ester derivative
CN106660984A (zh) * 2014-03-11 2017-05-10 Ea制药株式会社 杂芳基羧酸酯衍生物的制造方法、其制造中间体及晶体
EP3118196A4 (en) 2014-03-11 2018-02-21 EA Pharma Co., Ltd. Method for producing heteroarylcarboxylic acid ester derivative, and production intermediate of same
US10980866B2 (en) * 2014-09-22 2021-04-20 Hadasit Medical Research Services And Development Ltd. Alpha-1 anti-trypsin for treating liver diseases
EP3437651A1 (en) * 2017-08-03 2019-02-06 Université de Strasbourg Peptides for treatment and prevention of nonalcoholic fatty liver disease

Also Published As

Publication number Publication date
BR112023002069A2 (pt) 2023-03-07
JP2023103420A (ja) 2023-07-26
DK4166137T3 (da) 2024-06-17
CN115605198B (zh) 2026-04-10
FI4166137T3 (fi) 2024-07-01
TW202214231A (zh) 2022-04-16
EP4166137A4 (en) 2023-06-28
CN115605198A (zh) 2023-01-13
CA3183428A1 (en) 2022-02-24
EP4166137A1 (en) 2023-04-19
EP4166137B1 (en) 2024-05-29
ES2982263T3 (es) 2024-10-15
AU2021328824A1 (en) 2023-02-02
MX2023001742A (es) 2023-02-22
WO2022039178A1 (ja) 2022-02-24
PT4166137T (pt) 2024-06-25
JPWO2022039178A1 (pl) 2022-02-24
JP7286222B2 (ja) 2023-06-05
JP7756126B2 (ja) 2025-10-17
US20230201163A1 (en) 2023-06-29
KR20230052845A (ko) 2023-04-20
AU2021328824B2 (en) 2026-06-25
TWI906348B (zh) 2025-12-01
US12023320B2 (en) 2024-07-02

Similar Documents

Publication Publication Date Title
EP4164748C0 (en) CYCLOPROPYL-DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS
PL3661373T3 (pl) Kompozycja farmaceutyczna na niedokrwistość
EP4352684C0 (en) OUTPUT PROCESSOR
IL309412A (en) A tray for transferring medication to the area under the teeth
JP1786576S (ja) 靴
EP4081296C0 (en) COMPOUNDS DERIVED FROM DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE
DK4166137T3 (da) Terapeutisk middel mod fedtleversygdom
EP4172142A4 (en) BRANCHED LIPID COMPOUNDS
EP3957365A4 (en) Lipoic acid prodrug
EP4494644A4 (en) LIPID COMPOSITION
EP4132559A4 (en) MODIFIED KISSPEPTIN RECEPTOR AGONISTS FOR FATTY LIVER DISEASE
EP4463988A4 (en) PHASE 2 SCI DESIGN
ES1304246Y (es) Expositor modular para maquetas
IL316033A (en) Novel composition
EP4387785A4 (en) METHOD OF MAKING A MOLD
EP4275555C0 (en) WITHDRAWAL MECHANISM
JP1721987S (ja) 流し台用流し
JP1721986S (ja) 流し台用流し
JP1721985S (ja) 流し台用流し
JP1725001S (ja) 流し台用流し
UA44129S (uk) Етикетка-наліпка для клейових стрижнів
JP1719202S (ja) ボックスファイル
JP1719186S (ja) ボックスファイル
CA211816S (fr) Ecrin à huîtres
EP4583821A4 (en) REVISION FEMUR PROSTHESIS